Exact Mass: 370.05392020000005
Exact Mass Matches: 370.05392020000005
Found 266 metabolites which its exact mass value is equals to given mass value 370.05392020000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Thiophanate
CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8618; ORIGINAL_PRECURSOR_SCAN_NO 8617 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4116; ORIGINAL_PRECURSOR_SCAN_NO 4115 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4103; ORIGINAL_PRECURSOR_SCAN_NO 4099 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4122; ORIGINAL_PRECURSOR_SCAN_NO 4120 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8587; ORIGINAL_PRECURSOR_SCAN_NO 8585 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4090; ORIGINAL_PRECURSOR_SCAN_NO 4085 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8620; ORIGINAL_PRECURSOR_SCAN_NO 8618 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8603; ORIGINAL_PRECURSOR_SCAN_NO 8601 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8583; ORIGINAL_PRECURSOR_SCAN_NO 8581 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4112; ORIGINAL_PRECURSOR_SCAN_NO 4109 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8619; ORIGINAL_PRECURSOR_SCAN_NO 8617 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4113; ORIGINAL_PRECURSOR_SCAN_NO 4112 ORIGINAL_PRECURSOR_SCAN_NO 8618; CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8620 D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D016573 - Agrochemicals D010575 - Pesticides
4-O-alpha-D-Galactopyranuronosyl-D-galacturonic acid
Prepd. from pectin by enzymic hydrolysis using yeast or mould pectinases or by acid hydrolysis. Sole or major repeating unit of the pectin class of polysaccharides. Prepd. from pectin by enzymic hydrolysis using yeast or mould pectinases or by acid hydrolysis. Sole or major repeating unit of the pectin class of polysaccharides KEIO_ID D100
Fraxin
Fraxin is a beta-D-glucoside that is fraxetin attached to a beta-D-glucopyranosyl group at position 8 via a glycosidic linkage. It is a natural product isolated from the leaves of Fraxinus excelsior and exhibits potent hepatoprotective effects in vitro and in vivo. It has a role as a plant metabolite, an anti-inflammatory agent and a hepatoprotective agent. It is a beta-D-glucoside, a hydroxycoumarin and an aromatic ether. It is functionally related to a fraxetin. Fraxin is a natural product found in Acer nikoense, Prunus prostrata, and other organisms with data available. A beta-D-glucoside that is fraxetin attached to a beta-D-glucopyranosyl group at position 8 via a glycosidic linkage. It is a natural product isolated from the leaves of Fraxinus excelsior and exhibits potent hepatoprotective effects in vitro and in vivo. Origin: Plant, Coumarins Fraxin isolated from Cortex Fraxini, is a glucoside of fraxetin and reported to exert potent anti-oxidative stress action[1], anti-inflammatory and antimetastatic properties. Fraxin shows its antioxidative effect through inhibition of cyclo AMP phosphodiesterase enzyme[2]. Fraxin isolated from Cortex Fraxini, is a glucoside of fraxetin and reported to exert potent anti-oxidative stress action[1], anti-inflammatory and antimetastatic properties. Fraxin shows its antioxidative effect through inhibition of cyclo AMP phosphodiesterase enzyme[2].
Sedoheptulose 1,7-bisphosphate
This compound belongs to the family of Monosaccharide Phosphates. These are monosaccharides comprising a phosphated group linked tot he carbohydrate unit.
1,2-beta-D-Glucuronosyl-D-glucuronate
D-glycero-D-manno-Heptose 1,7-bisphosphate
D-glycero-D-manno-heptose in which the hydrogens of the hydroxy groups at positions 1 and 7 are substituted by dihydrogen phosphate groups.
Transfluthrin
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals Same as: D01932
Azosemide
C12H11ClN6O2S2 (370.00734159999996)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides D045283 - Natriuretic Agents > D004232 - Diuretics
D-glycero-alpha-D-manno-heptose 1,7-bisphosphate
D-glycero-alpha-D-manno-heptose in which the hydrogens of the hydroxy groups at positions 1 and 7 are substituted by dihydrogen phosphate groups.
2-O-Caffeoylhydroxycitric acid
Constituent of Spondias mombin (yellow mombin) and Zea mays (sweet corn). 2-O-Caffeoylhydroxycitric acid is found in many foods, some of which are cereals and cereal products, fats and oils, corn, and fruits. 2-O-Caffeoylhydroxycitric acid is found in cereals and cereal products. 2-O-Caffeoylhydroxycitric acid is a constituent of Spondias mombin (yellow mombin) and Zea mays (sweet corn).
5-Hydroxy-6-methoxycoumarin 7-glucoside
5-Hydroxy-6-methoxycoumarin 7-glucoside is found in alcoholic beverages. 5-Hydroxy-6-methoxycoumarin 7-glucoside is isolated from Prunus spinosa (sloe). Isolated from Prunus spinosa (sloe). 5-Hydroxy-6-methoxycoumarin 7-glucoside is found in alcoholic beverages, herbs and spices, and fruits.
Suillusin
Suillusin is found in mushrooms. Suillusin is isolated from the mushroom Suillus granulatus (granulated bolete).
Remoxipride
Remoxipride is only found in individuals that have used or taken this drug. It is an antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia. [PubChem]Remoxipride acts as an antagonist at the D2 dopamine receptor. It is believed that overactivity of dopamine systems in the mesolimbic pathway may contribute to the "positive symptoms" of schizophrenia (such as delusions and hallucinations), whereas problems with dopamine function in the mesocortical pathway may be responsible for the "negative symptoms", such as avolition, flat emotional response and alogia. Therefore, by decreasing the levels of dopamine in these pathways, it is thought that remoxipride is able to reduce the symptoms of schizophrenia, particularily the "positive symptoms". D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
Ferulic acid 4-O-glucuronide
Ferulic acid 4-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313). Ferulic acid 4-O-glucuronide was found to be elevated in rat urine after whole rye consumption which makes this compound a potential urinary biomarker of whole grain intake (PMID: 26862900).
Feruloyl C1-glucuronide
Feruloyl C1-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Isoferulic acid 3-O-glucuronide
Isoferulic acid 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Isoferuloyl C1-glucuronide
Isoferuloyl C1-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Azosemide
C12H11ClN6O2S2 (370.00734159999996)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides D045283 - Natriuretic Agents > D004232 - Diuretics Azosemide is a high-ceiling diuretic agent.
Catechin 7-sulfate
C15H14O9S (370.03585140000007)
Catechin 3-sulfate
C15H14O9S (370.03585140000007)
Catechin 3'-sulfate
C15H14O9S (370.03585140000007)
Catechin 4'-sulfate
C15H14O9S (370.03585140000007)
Catechin 5-sulfate
C15H14O9S (370.03585140000007)
Epicatechin 3-sulfate
C15H14O9S (370.03585140000007)
A human metabolite taken as a putative food compound of mammalian origin [HMDB]. Epicatechin sulfate in the urine is a biomarker for the consumption of legumes.
Epicatechin 3'-sulfate
C15H14O9S (370.03585140000007)
Epicatechin 4'-sulfate
C15H14O9S (370.03585140000007)
Epicatechin 5-sulfate
C15H14O9S (370.03585140000007)
Epicatechin 7-sulfate
C15H14O9S (370.03585140000007)
cis-Ferulic acid 4-glucuronide
2-Oxoquazepam
[(2R,3R,4R,5S)-3,4-Diacetyloxy-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl acetate
3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione
4-[[4-Amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile
8-Azido-cyclic AMP
C10H11N8O6P (370.05391560000004)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels
8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide
Parecoxib
C19H18N2O4S (370.0987228000001)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
rebamipide
C19H15ClN2O4 (370.07203000000004)
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D020011 - Protective Agents > D000975 - Antioxidants D004791 - Enzyme Inhibitors
n-[[(5-Methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide
C19H18N2O4S (370.0987228000001)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents
Tetomilast
C19H18N2O4S (370.0987228000001)
C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
Transfluthrin
5,3-dimethoxy-6,7:4,5-bis(methylenedioxy)isoflavone
5,2-dimethoxy-6,7:4,5-bis(methylenedioxy)isoflavone
6,7-Dihydroxy-5-methoxycoumarin 6-beta-D-glucopyranoside
Meliternatin
6-Methoxypulcherrimin
O1-(4-Chlorobenzoyl)-2-[(4-fluorophenyl)sulfonyl]ethanehydroximamide
Parecoxib
C19H18N2O4S (370.0987228000001)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
(E)-3-[6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3-benzodioxol-5-yl]prop-2-enoic acid
2,3,6,7,8,9-hexahydroxynaphthalene-2-O-alpha-L-(-)-rhamnopyranoside|arjunaphthanoloside
O1-[2-(3-Acetyl-carbazoyl)-phenyl]-beta-D-glucopyranuronsaeure|O1-[2-(3-acetyl-hydrazinocarbonyl)-phenyl]-beta-D-glucopyranuronic acid
Didemnimide D
C16H11BrN4O2 (370.00653259999996)
A natural product found in Didemnum species.
5,8-dihydroxy-7-methoxycoumarin-5-beta-glucopyranoside
Monnieriside A
Monnieriside A is a natural product found in Cnidium monnieri with data available.
2-methyl-5,7-dihydroxychromone 8-C-beta-D-glucopyranoside
3-O-(beta-D-Glucopyranosyluronsaeure)-D-galakturonsaeure
5,8,13,14-tetraoxa-pentaphene-1,3,6,9,11-pentaol|DDE|Dioxinodehydroeckol|eckstolonol
Mitoglitazone
C19H18N2O4S (370.0987228000001)
MSDC 0160 (Mitoglitazone) is a mitochondrial target of thiazolidinediones (mTOT)-modulating insulin sensitizer and a modulator of mitochondrial pyruvate carrier (MPC). MSDC 0160 is a thiazolidinedione (TZD) with antidiabetic and neuroprotective activities. MSDC 0160 has the potential for Alzheimer′s disease[1][2].
rebamipide
C19H15ClN2O4 (370.07203000000004)
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D020011 - Protective Agents > D000975 - Antioxidants D004791 - Enzyme Inhibitors
8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based: Match]
8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one_major
CAY10415
C19H18N2O4S (370.0987228000001)
MSDC 0160 (Mitoglitazone) is a mitochondrial target of thiazolidinediones (mTOT)-modulating insulin sensitizer and a modulator of mitochondrial pyruvate carrier (MPC). MSDC 0160 is a thiazolidinedione (TZD) with antidiabetic and neuroprotective activities. MSDC 0160 has the potential for Alzheimer′s disease[1][2].
Remoxipride
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
Suillusin
5-Hydroxy-6-methoxycoumarin 7-glucoside
2-O-Caffeoylhydroxycitric acid
Ferulic acid 4-O-glucuronide
Feruloyl C1-glucuronide
Isoferulic acid 3-O-glucuronide
Isoferuloyl C1-glucuronide
Diart
C12H11ClN6O2S2 (370.00734159999996)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides D045283 - Natriuretic Agents > D004232 - Diuretics
Pyrimido[4,5-g]quinazoline-4,9-dione,2,7-bis(chloromethyl)-3,8-dihydro-5,10-dihydroxy-3,8-dimethyl-
bis[2,8-di(trifluoromethyl)quinolin-4-yl-2-pyridyl] ketone
C17H8F6N2O (370.05407899999994)
6-chloro-3-indoxyl-n-acetyl-beta-d-galactosaminide
Phosphonium,(2-carboxyethyl)triphenyl-, chloride (1:1)
C21H20ClO2P (370.08893800000004)
2-(4-BROMOPHENYL)-PROPANEDIOIC ACID 1,3-BIS-T-BUTYL ESTER
4-Thiazolidinone,5-(3-methyl-2(3H)-benzothiazolylidene)-3-(phenylmethyl)-2-thioxo-
3-(2-Chloro-4-pyrimidinyl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]py ridine
carbomethoxymethyl triphenylphosphonium chloride
C21H20ClO2P (370.08893800000004)
2,2,3,3,4,4,5,5-octafluoro-1,6-hexanediol diacrylate
C12H10F8O4 (370.04513160000005)
Magnesium salicylate
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D004791 - Enzyme Inhibitors
1H-Pyrrolo[2,3-b]pyridine, 5-bromo-4-fluoro-1-[tris(1-methylethyl)silyl]-
C16H24BrFN2Si (370.08760559999996)
(+)-1,4-BIS-O-(4-CHLOROBENZYL)-D-THREITOL
C18H20Cl2O4 (370.07385800000003)
uridine triacetate
A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products C78275 - Agent Affecting Blood or Body Fluid Uridine triacetate (Tri-O-acetyl uridine) is an orally active proagent of Uridine (HY-B1449). Uridine triacetate is quickly absorbed in the gut, and is rapidly deacetylated in the circulation to yield free uridine. Uridine triacetate is used for the research of 5-fluorouracil (5-FU) and capecitabine toxicity, or early-onset cardiac or central nervous system (CNS)[1][2].
Ethyl(triphenyl)phosphonium bromide
C20H20BrP (370.04859100000004)
Premarin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen
4-Quinolinepropanoic acid, α-[(3-chlorobenzoyl)amino]-1,2-dihydro-2-oxo
C19H15ClN2O4 (370.07203000000004)
3-(4-BROMOPHENYL)-1-PHENYLPYRAZOLE-4-PROPIONIC ACID
5-(iodomethyl)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydro-3aH-di[1,3]dioxolo[4,5-a:5,4-d]pyran
2-(2-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
C19H15ClN2O4 (370.07203000000004)
Thiourea, N-[4-(4-chlorophenyl)-5-methyl-1H-pyrazol-3-yl]-N-(2-phenylethyl)- (9CI)
2,3-BIS(4-FLUOROPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE
3-(2-bromoacetyl)-10,11-dihydro-5H-Benzo[d]naphtho[2,3-b]pyran-8(9H)-one
N,N-di-(4-pyridyl)-1,2,4,5-benzenetetracarboxydiimide
C20H10N4O4 (370.07020200000005)
2,3-BIS(3-FLUOROPHENYL)-5-PHENYLTETRAZOLIUMCHLORIDE
N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide
C19H18N2O4S (370.0987228000001)
(5E)-2-mercapto-3-phenyl-5-(2,4,5-trimethoxybenzylidene)-3,5-dihydro-4H-imidazol-4-one
C19H18N2O4S (370.0987228000001)
Adenosine, 5-(dihydrogen phosphorothioate), dilithium salt
C10H14LiN5O6PS (370.0562444000001)
4-O-alpha-D-Galactopyranuronosyl-alpha-D-galactopyranuronic acid
8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide
2-[[3-Cyano-6-(2-furanyl)-4-(trifluoromethyl)-2-pyridinyl]thio]propanoic acid ethyl ester
C16H13F3N2O3S (370.0598944000001)
4-Hydroxy-5-[oxo(thiophen-2-yl)methyl]-6-phenyl-4-(trifluoromethyl)-1,3-diazinan-2-one
C16H13F3N2O3S (370.0598944000001)
Sodium ferric EDTA
B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AB - Iron trivalent, oral preparations D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds
4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-YL)amino]methyl}phenyl sulfamate
C16H14N6O3S (370.08480540000005)
Iron(4+);2-[[2-[(2-oxidophenyl)methylideneamino]phenyl]iminomethyl]phenolate
C20H14FeN2O2+2 (370.04046139999997)
N-(4-acetamidophenyl)-3-(5-chloro-2-hydroxyphenyl)-1H-pyrazole-5-carboxamide
4-[2-Amino-5-(4-methylsulfonylphenyl)-3-pyridyl]-2-methoxy-phenol
C19H18N2O4S (370.0987228000001)
D-glycero-beta-D-manno-Heptose 1,7-bisphosphate
D-glycero-beta-D-manno-heptose in which the hydrogens of the hydroxy groups at positions 1 and 7 are substituted by dihydrogen phosphate groups.
(4-Biphenyl-4-yl-1-phosphono-butyl)-phosphonic acid
N-acetylmuramic acid 1-phosphate
C11H17NO11P-3 (370.05392020000005)
2-(beta-D-glucopyranosyluronic acid)-D-glucuronic acid
1-Phosphono-4-(1,1-biphenyl-4-yl)-1-butanesulfonic acid
[(1R,2R,3S,4S)-4-{5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-2,3-dihydroxycyclopentyl]methyl phosphate
C12H11N4O8P-2 (370.03144960000003)
N-acetyl-beta-muramate 6-phosphate
C11H17NO11P-3 (370.05392020000005)
2-(4-Bromophenyl)-3,5-dimethyl-4-oxido-6-phenylpyrazin-1-ium 1-oxide
[5-hydroxy-3-(4-methoxyphenyl)-5-(trifluoromethyl)-4H-pyrazol-1-yl]-thiophen-2-ylmethanone
C16H13F3N2O3S (370.0598944000001)
2,3-Dimethyl-6-quinoxalinecarboxylic acid (2-bromophenyl)methyl ester
4-[(2-chloro-3-phenyl-2-propen-1-ylidene)amino]-5-(phenoxymethyl)-4H-1,2,4-triazole-3-thiol
C18H15ClN4OS (370.06550500000003)
4-[(6-nitro-1,3-benzodioxol-5-yl)methyleneamino]-3-(2-pyridyl)-1H-1,2,4-triazole-5-thione
C15H10N6O4S (370.0484220000001)
N-(2-furanylmethyl)-4-(1-pyrrolidinylsulfonyl)benzenesulfonamide
N-(2-hydroxyethyl)-4-[2-nitro-4-(trifluoromethyl)phenoxy]benzamide
C16H13F3N2O5 (370.07765240000003)
N-(1H-indazol-6-yl)-2-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]acetamide
4-Amino-furazan-3-carboxylic acid [5-(2,4-dimethyl-5-nitro-phenyl)-furan-2-ylmethylene]-hydrazide
5-(1,3-Benzodioxol-5-yl)-4-(1-methyltetrazol-5-yl)sulfanylthieno[2,3-d]pyrimidine
D-Galacturonic acid, 4-O-a-D-galactopyranuronosyl-
1-O-[N-(2-hydroxybenzoyl)glycyl]-beta-D-glucuronate
[2-hydroxy-5-(3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-2-yl)phenyl]oxidanesulfonic acid
C15H14O9S (370.03585140000007)
6-[3-[(E)-2-carboxyethenyl]-5-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Thiophanate
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D016573 - Agrochemicals D010575 - Pesticides
Premarin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen
Eckstolonol
A phlorotannin that is [1,4]benzodioxino[2,3-a]oxanthrene substituted by hydroxy groups at positions 1, 3, 6, 9 and 11. Isolated from the brown alga Ecklonia stolonifera, it exhibits radical scavenging activity.
N-acetyl-beta-muramate 6-phosphate
C11H17NO11P (370.05392020000005)
An organophosphate oxoanion that is a trianion arising from deprotonation of phosphate and carboxylic acid functions of N-acetyl-beta-muramic acid 6-phosphate.
N-acetylmuramate 6-phosphate
C11H17NO11P (370.05392020000005)
An organophosphate oxoanion that is a trianion arising from deprotonation of the phosphate and carboxylic acid functions of N-acetylmuramic acid 6-phosphate.
alpha-D-GalpA-(1->4)-alpha-D-GalpA
A alpha-D-GalpA-(1->4)-D-GalpA in which the anomeric hydroxy group has alpha- configuration.
4-(6-bromo-1h-indol-3-yl)-5-hydroxy-3-(3-methylimidazol-4-yl)pyrrol-2-one
C16H11BrN4O2 (370.00653259999996)
1-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2-hydroxypropane-1,2,3-tricarboxylic acid
(1r,3r,4s,6r,7r)-4-bromo-3-ethyl-9-[(2z)-pent-2-en-4-yn-1-yl]-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate
8-hydroxy-7-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
16-hydroxy-17,18-dimethoxy-6,8,12,21-tetraoxapentacyclo[11.8.0.0²,¹⁰.0⁵,⁹.0¹⁵,²⁰]henicosa-1(13),2(10),3,5(9),15,17,19-heptaen-14-one
(1r,3r,4s,6r,7r,9r)-4-bromo-3-ethyl-9-[(2e)-pent-2-en-4-yn-1-yl]-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate
(1r,2s,3r,4s)-11-(diazyn-1-ium-1-yl)-1,2,3,4,10-pentahydroxy-2-methyl-5-oxo-1h,3h,4h-benzo[b]fluoren-9-olate
8-hydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
amsonicacid
{"Ingredient_id": "HBIN015913","Ingredient_name": "amsonicacid","Alias": "NA","Ingredient_formula": "C14H14N2O6S2","Ingredient_Smile": "C1=CC(=C(C=C1N)S(=O)(=O)O)C=CC2=C(C=C(C=C2)N)S(=O)(=O)O","Ingredient_weight": "370.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1088","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5284378","DrugBank_id": "NA"}
methyl (2s,6r)-5-(3,4-dihydroxyphenyl)-4,11-dihydroxy-3-oxo-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraene-6-carboxylate
9-methoxy-7-(6-methoxy-2h-1,3-benzodioxol-5-yl)-2h-[1,3]dioxolo[4,5-g]chromen-8-one
[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-[(1r)-1-hydroxy-2-(phosphonooxy)ethyl]oxan-2-yl]oxyphosphonic acid
(11r)-11-(2-carbamimidamidoethyl)-8-hydroxy-13-oxo-12,15-dioxa-4-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1(16),2,4,6,8,10(14)-hexaene-3-carboxylic acid
(1r,2r,3s,4s)-1,2,3,4,9-pentahydroxy-2-methyl-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluorene-5,10-dione
7-hydroxy-5-methoxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
11-(2-carbamimidamidoethyl)-8-hydroxy-13-oxo-12,15-dioxa-4-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1(16),2,4,6,8,10(14)-hexaene-3-carboxylic acid
2,5-dihydroxy-3-(1h-indol-2-yl)-6-(1h-indol-3-yl)cyclohexa-2,5-diene-1,4-dione
5,10,12-trihydroxy-8-methoxy-3-methyl-3,4-dihydro-2-oxatetracene-1,6,11-trione
2,5-dihydroxy-3,6-bis(1h-indol-3-yl)cyclohexa-2,5-diene-1,4-dione
(2s,5'as,6's,10'ar)-1',6'-dihydroxy-10'a-(methylsulfanyl)-6',10'-dihydro-3h,5'ah-spiro[1-benzofuran-2,3'-pyrazino[1,2-a]indol]-4'-one
C19H18N2O4S (370.0987228000001)
3-[(2e)-4-(3,4-dihydroxyphenyl)-3-hydroxy-5-oxofuran-2-ylidene]-6,7-dihydroxy-1-benzofuran-2-one
11,22-diazapentacyclo[13.7.0.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosa-1,3,5,7,9,12,14,16,18,20-decaene-2,13-dicarboxylic acid
1',6'-dihydroxy-10'a-(methylsulfanyl)-6',10'-dihydro-3h,5'ah-spiro[1-benzofuran-2,3'-pyrazino[1,2-a]indol]-4'-one
C19H18N2O4S (370.0987228000001)
5-hydroxy-13-methoxy-6,11-dimethyl-2,8,16,19-tetraoxapentacyclo[12.4.2.0⁴,¹⁸.0⁷,¹⁷.0¹⁰,¹⁵]icosa-4,6,10,12,14,17-hexaene-3,9-dione
(1s)-5-hydroxy-13-methoxy-6,11-dimethyl-2,8,16,19-tetraoxapentacyclo[12.4.2.0⁴,¹⁸.0⁷,¹⁷.0¹⁰,¹⁵]icosa-4,6,10,12,14,17-hexaene-3,9-dione
[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-[(1r)-1-hydroxy-2-(phosphonooxy)ethyl]oxan-2-yl]oxyphosphonic acid
9-methoxy-7-(7-methoxy-2h-1,3-benzodioxol-5-yl)-2h-[1,3]dioxolo[4,5-g]chromen-8-one
(3r)-5,10,12-trihydroxy-8-methoxy-3-methyl-3,4-dihydro-2-oxatetracene-1,6,11-trione
5-hydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
1,2,3,4,9-pentahydroxy-2-methyl-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluorene-5,10-dione
13-hydroxy-5-methoxy-7,12-dimethyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3,5,7,11,13-hexaene-4-carbaldehyde
(2r,5'as,6's,10'ar)-1',6'-dihydroxy-10'a-(methylsulfanyl)-6',10'-dihydro-3h,5'ah-spiro[1-benzofuran-2,3'-pyrazino[1,2-a]indol]-4'-one
C19H18N2O4S (370.0987228000001)